Truist Securities Downgrades Insulet to Hold, Lowers Price Target to $153

Benzinga Newsdesk www.benzinga.com Negative 90.7%

Neg 90.7% Neu 0% Pos 0%

Truist Securities analyst Richard Newitter downgrades Insulet (NASDAQ:PODD) from Buy to Hold and lowers the price target from $210 to $153.